iknoweverything’s Post

In anticipation of the #TXPHS24 on zoonotic health risks, this upcoming TEPHI Grand Rounds webinar explores the pathophysiology of dengue and severe dengue. Join guest speaker, Trevor Wellington, MD, as he discusses this common disease affecting up to 400 million people annually. The webinar focuses on the reasons behind the rising number of cases and the role of serotype exposure in determining disease severity. Register: https://lnkd.in/dgfQPVZc

Fungal diseases pose significant challenges, especially for individuals with weakened immune systems, often leading to a considerable impact on their quality of life. Addressing these challenges requires targeted approaches to prevention, diagnosis, and treatment to enhance health outcomes. Join us for this ECHO WARE session as Dr. Adamu Abba Adamu shares expert insights into the effective management of fungal diseases in immunosuppressed populations. click here to register and join the meeting: https:// bit.ly/3H04G4u #PHIS3 #ECHOWARE

🌍18 to 24 November marks World AMR Awareness Week, shedding light on the critical issue of Antimicrobial🌎 Resistance (AMR). AMR occurs when bacteria, viruses, fungi, and parasites evolve over time, rendering medications ineffective. This phenomenon poses a significant challenge in treating infections, leading to severe illnesses and elevated risks of disease transmission and mortality. The global community recognized the urgency of addressing antibiotic resistance at the Sixty-eighth World Health Assembly in May 2015. A comprehensive action plan was adopted to combat the escalating threat posed by AMR. Central to this plan is the imperative to enhance awareness and comprehension of AMR through robust communication, education, and training initiatives. World AMR Awareness Week (WAAW) serves as a pivotal global campaign observed annually to foster understanding and awareness of AMR. By promoting best practices among the public, One Health stakeholders, and policymakers, WAAW aims to mitigate the proliferation and dissemination of AMR. Together, we can strive to curb the advancement of antimicrobial resistance and safeguard public health. #AMRAwarenessWeek #Join_the_fight.

📢 Join Us for a Vital Discussion: The Silent Epidemic - The Need for a Stronger IFI Response Invasive Fungal Infections (IFIs) are an often-overlooked but critical global health threat. 🌍 Join us for The Silent Epidemic, a virtual seminar featuring renowned experts, as we conclude our awareness series on IFIs. Together, we’ll explore the current challenges, innovative strategies, and the urgent need for action. 🗓 Key Dates: November 25th December 2nd 🕘 9:00 AM PST | 12:00 PM EST 🎙 Why Attend? ✔ Learn about the global impact of IFIs ✔ Gain insights from leading experts ✔ Be part of the solution for a stronger IFI response 👉 RSVP USING LINK BELOW! Help us shine a light on this silent epidemic and drive meaningful change! 🌟 #IFIAwareness #HealthInnovation #GlobalHealth

Today, May 12 is the World Gum Health Day.   As a reminder: 📍 NO oral prevention policy in France (according to WHO) 📍 2006: In France, ONE IN 2 ADULTS PRESENTS PERIODONTITIS according to the latest epidemiological study on the prevalence of periodontal diseases. NO studies for 18 years. 📍 2020: In France, 63% of adults have BLEEDING gums and, for 83% of them, IT IS BENIN 📍 2023: a study bringing together epidemiological data from 24 countries including several European countries, excluding France, shows an INCREASE IN THE PREVALENCE OF PERIODONTITIS. 📍 FOR 40 YEARS, thousands of studies have shown the direct or indirect relationships between periodontal disease and general health. IT IS HIGH TIME TO TAKE CARE OF PERIODONTAL DISEASE.

🚨 Happening TODAY at 11AM CT! 🚨 Join the Public Health Innovation Lab (PHiL) for The Silent Epidemic: The Need for a Stronger IFI Response. 🌍 Invasive fungal infections (IFI) are a global health crisis affecting millions, yet they remain underrecognized and underfunded. This webinar will dive into: 🔎 The impact of IFIs worldwide 📉 Gaps in the current response 💡 Strategies for stronger global & local efforts 💬 Hear from an expert panel: Dr. Tom Chiller (CDC) Dr. Eric Goosby (UCSF) Oddi Aasheim (GAFFI) 📅 Free registration is still open! Join the conversation to raise awareness and drive change. 🔗 Register now and join us at 11AM: https://hubs.ly/Q02ZkBH80 (Details will also be shared live, so don’t miss out!) #SilentEpidemic #IFIResponse #FungalInfections #PublicHealth

Dive into the latest UPMC HealthBeat article where Karin E. Byers, MD, MS, Associate Chief of Clinical Care and Clinical Director of the ID Division, breaks down the crucial differences between Tuberculosis (TB) and Nontuberculous Mycobacteria (NTM). TB, though rare in the US, remains a significant global health concern, spreading through the air when an infected person coughs or sneezes. In contrast, NTM, found in our environment, typically doesn't cause illness unless an individual has underlying health issues or a weakened immune system. Discover more about these diseases, their impact on lung health, and why understanding the distinction matters. Follow the link below to read more! https://lnkd.in/eJGKwhug #UPMC #HealthBeat #TB #NTM #idpittstop

🤝#ECRD2024 Wonderful panel session showing the different perspectives and proposal of solutions for the key challenges on access to innovative treatments on rare diseases! ✅ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases) represented by Mariangela Pellegrini, Patients Manager. #ERNeu #ERNs #HealthUnion #EU4Health #ShareCareCure European Commission European Health and Digital Executive Agency (HaDEA) EURORDIS-Rare Diseases Europe

𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐂𝐚𝐫𝐞: 𝐒𝐩𝐮𝐭𝐮𝐦 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 The Global #Sputum_Test_Market is valued at USD 2.1 billion in 2022 and is estimated to grow at a CAGR of around 5.7% during the forecast period, i.e., 2024-30. The market is driven by the increasing prevalence of respiratory diseases such as Tuberculosis, Pneumonia, and chronic obstructive pulmonary diseases. Technological advancements in diagnostic methods, rising management, growing awareness about early disease detection, and the increasing ratio of finance are other factors that directly support the Sputum Test Market. ✅𝐉𝐮𝐬𝐭 𝐢𝐧 𝐎𝐧𝐞 𝐂𝐥𝐢𝐜𝐤, 𝐆𝐞𝐭 𝐔𝐧𝐩𝐚𝐢𝐝 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐒𝐚𝐦𝐩𝐥𝐞:https://lnkd.in/grd6W2Fg #SputumTestMarket #RespiratoryHealth #DiagnosticTesting #HealthcareInnovation #InfectiousDisease #LungHealth #MedicalTechnology #PublicHealth #InnovationsInHealthcare #EarlyDetection #DiseasePrevention #MedicalAdvancements #GlobalHealth #HealthcareIndustry #ScreeningTests

🔍 Understanding Disease X:🦠 Disease X represents a hypothetical, unknown pathogen that could cause a future epidemic. It's a placeholder for the next big infectious disease that could emerge and spread rapidly, challenging our healthcare systems and societies. 🧠 Why It Matters: Preparedness: Disease X emphasizes the importance of being ready for the unexpected. It reminds us that while we may not know the specifics, we can strengthen our global health infrastructure to respond swiftly and effectively. Innovation: The concept drives innovation in research and development, encouraging scientists to think beyond current diseases and develop broad-spectrum treatments and vaccines. Collaboration: It highlights the need for international cooperation, as diseases know no borders. Sharing knowledge and resources is crucial in combating potential threats. 💡 What Can We Do? Stay Informed: Keep up with the latest research and developments in global health. Support Science: Advocate for funding and support for scientific research and public health initiatives. Promote Awareness: Educate others about the importance of preparedness and the role each of us plays in preventing the spread of diseases. 🔗 Join the Conversation: What are your thoughts on Disease X? How can we better prepare for the unknown? Share your insights and let's discuss how we can collectively safeguard our future. #DiseaseX #GlobalHealth #PublicHealth #Innovation #Preparedness #Healthcare #Collaboration #FutureOfHealth